VVOS
Vivos Therapeutics, Inc. Common StockstockNASDAQ
Market OpenNov 16, 2026 11:31:56 AM EST
0.09USD-5.816%(-0.01)514,119
Pre-marketNov 16, 2026 9:11:30 AM EST
0.097USD-1.020%(-0.001)
VVOS Financials
In Q2 FY 2026 (ended ), Vivos Therapeutics, Inc. Common Stock (VVOS) reported revenue of $5.15M, net income of −$5.48M, operating cash flow of −$3.15M, and assets of $24.14M (filed ).
Loading business breakdowns…